OTCMKTS:AXIM

Axim Biotechnologies Stock Insider Trading

Healthcare > Biotechnology

Buy AXIM

*Your capital is at risk

$0.0031

-0.000011 (-0.354%)

At Close: Jul 31, 2026

AXIM Biotechnologies Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at 0. In total, the insiders bought 78.47M and sold 46M AXIM shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	0
● Buy	78.47M shares
● Sell	46M shares
94% Buy Activity Negligible or No Correlation
No Significant Signals No statistically significant buy or sell signals detected in recent insider data.

Historical Insider Trades

Date	Type	Person	Role	Amount
Mar 19, 2020 Buy	Common Stock	Glycodots, Llc 10 Percent Owner	10% Owner	0 Value: $0
Mar 19, 2020 Buy	Common Stock	Valencia Catalina 10 Percent Owner	10% Owner	0 Value: $0
Jan 02, 2019 Buy	Option A-Award	Huemoeller John Walter Ii Chief Executive Officer	CEO / President	2 000 000 Value: $1.50M
Jan 02, 2019 Buy	Option A-Award	Huemoeller John Walter Ii Chief Executive Officer	CEO / President	2 000 000 Value: $1.50M
Mar 21, 2018 Buy	Common Stock A-Award	Malasek Robert CFO	C-Suite Officer	50 000 Value: $0
Mar 21, 2018 Buy	Common Stock A-Award	Malasek Robert CFO	C-Suite Officer	50 000 Value: $0
May 18, 2017 Buy	Common Stock	Schroeder Blake Director	Director	0 Value: $0
May 18, 2017 Buy	Preferred Stock	Schroeder Blake Director	Director	0 Value: $0
May 18, 2017 Buy	Common Stock	Scott Timothy Richard Director	Director	0 Value: $0
May 18, 2017 Buy	Preferred Stock	Scott Timothy Richard Director	Director	0 Value: $0
May 18, 2017 Buy	Common Stock	Huemoeller John Walter Ii Director	Director	0 Value: $0
May 18, 2017 Buy	Preferred Stock	Huemoeller John Walter Ii Director	Director	0 Value: $0
May 18, 2017 Buy	Common Stock	Cunningham Robert L Director	Director	0 Value: $0
May 18, 2017 Buy	Preferred Stock	Cunningham Robert L Director	Director	0 Value: $0
May 18, 2017 Buy	Common Stock	Schroeder Blake Director	Director	0 Value: $0
May 18, 2017 Buy	Preferred Stock	Schroeder Blake Director	Director	0 Value: $0
May 18, 2017 Buy	Common Stock	Scott Timothy Richard Director	Director	0 Value: $0
May 18, 2017 Buy	Preferred Stock	Scott Timothy Richard Director	Director	0 Value: $0
May 18, 2017 Buy	Common Stock	Huemoeller John Walter Ii Director	Director	0 Value: $0
May 18, 2017 Buy	Preferred Stock	Huemoeller John Walter Ii Director	Director	0 Value: $0
May 18, 2017 Buy	Common Stock	Cunningham Robert L Director	Director	0 Value: $0
May 18, 2017 Buy	Preferred Stock	Cunningham Robert L Director	Director	0 Value: $0
Dec 31, 2016 Buy	Common Stock J-Other	Medical Marijuana Inc	10% Owner	0 Value: $0
Dec 31, 2016 Buy	Common Stock J-Other	Medical Marijuana Inc	10% Owner	0 Value: $0
Dec 31, 2016 Buy	Common Stock J-Other	Medical Marijuana Inc	10% Owner	0 Value: $0

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT AXIM BIOTECHNOLOGIES, INC.

AXIM Biotechnologies, Inc. develops and sells diagnostic healthcare solutions in the areas of SARS-CoV-2, eye health, and oncology. The company is developing rapid diagnostic tests, which measure the levels of functional neutralizing antibodies that prevent SARS-CoV-2 from attaching to human cells; serological diagnostic test, which detect neutralizing antibodies that measure adaptive immune response to the SARS-CoV-2 virus; and tests for managem...

Read Full Profile Here